Rationales for micronutrient supplementation in diabetes.
Available evidence--some well-documented, some only preliminary--suggests that properly-designed nutritional insurance supplementation may have particular value in diabetes. Comprehensive micronutrient supplementation providing ample doses of antioxidants, yeast-chromium, magnesium, zinc, pyridoxine, gamma-linolenic acid, and carnitine, may aid glucose tolerance, stimulate immune defenses, and promote wound healing, while reducing the risk and severity of some of the secondary complications of diabetes.
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use; D001205:Ascorbic Acid / Q000627:therapeutic use; D002118:Calcium / Q000627:therapeutic use; D002331:Carnitine / Q000627:therapeutic use; D002857:Chromium / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy*; D006801:Humans; D008042:Linolenic Acids / Q000627:therapeutic use; D008274:Magnesium / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use; D012643:Selenium / Q000627:therapeutic use; D008063:Thioctic Acid / Q000627:therapeutic use; D014451:Ubiquinone / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use; D015032:Zinc / Q000627:therapeutic use; D017965:gamma-Linolenic Acid
D000975:Antioxidants; D008042:Linolenic Acids; D002857:Chromium; D014451:Ubiquinone; D014810:Vitamin E; D008063:Thioctic Acid; D017965:gamma-Linolenic Acid; D012643:Selenium; D008274:Magnesium; D015032:Zinc; D011736:Pyridoxine; D001205:Ascorbic Acid; D002331:Carnitine; D002118:Calcium